Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Various Advanced Cancer × Fluorouracil × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 39 Stomach Neoplasms 20 Pancreatic Neoplasms 16 Rectal Neoplasms 13 Esophageal Neoplasms 12 Colonic Neoplasms 11 Adenocarcinoma Of Esophagus 10 Neoplasms 9 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Squamous Cell Carcinoma of Head and Neck 8 Cholangiocarcinoma 7 Biliary Tract Neoplasms 5 Urinary Bladder Neoplasms 4 Parkinson Disease 4, Autosomal Dominant Lewy Body 4 Ovarian Neoplasms 4 Esophageal Squamous Cell Carcinoma 4 Adenocarcinoma 4 Lung Neoplasms 3 Cirrhosis, Familial, with Pulmonary Hypertension 3 Anus Neoplasms 3 Advanced Solid Tumors 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Oropharyngeal Neoplasms 2 Melanoma 2 Head and Neck Neoplasms 2 HER2-positive Gastric Cancer 2 Gastrointestinal Neoplasms 2 Endometrial Neoplasms 2

Interventions

Nivolumab 1 Ipilimumab 1 Fluorouracil 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03143153 2026-02-17

CheckMate 648

Bristol-Myers Squibb

Phase 3 Completed

970 enrolled 15 charts 1 FDA

Various Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡